Ruprecht-Karls-Universität Heidelberg

University / College


Location: Heidelberg, Germany (DE) DE

ISNI: 0000000121904373

ROR: https://ror.org/038t36y30

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Bidirectional associations between psychological distress and hearing problems: an 18-year longitudinal analysis of the British Household Panel Survey (2018) Herr RM, Bosch JA, Theorell T, Loerbroks A Journal article Effort-reward imbalance among students at German universities: associations with self-rated health and mental health (2018) Hilger-Kolb J, Diehl K, Herr RM, Loerbroks A Journal article “Lost in the sun”—The key role of perceived workplace support for sun-protective behavior in outdoor workers (2018) Schilling L, Schneider S, Goerig T, Spengler M, Greinert R, Breitbart EW, Diehl K Journal article Barriers to using a nationwide skin cancer screening program: Findings from Germany (2018) Goerig T, Schneider S, Schilling L, Diehl K Journal article Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment (2018) Ott C, Gerken M, Hirsch D, Fest P, Fichtner-Feigl S, Munker S, Schnoy E, et al. Journal article Primary leiomyosarcoma of the skin: a comprehensive review on diagnosis and treatment (2018) Zacher M, Heppt MV, Brinker TJ, Hayani KM, Flaig MJ, Berking C Journal article, Review article MRI-based high-precision irradiation in an orthotopic pancreatic tumor mouse model: A treatment planning study MRT-basierte Hochpräzisionsstrahlentherapie im orthotopen Pankreastumor-Mausmodell: Eine Bestrahlungsplanungsstudie (2018) Dobiasch S, Kampfer S, Habermehl D, Duma MN, Felix K, Strauss A, Schilling D, et al. Journal article Impact of nab-paclitaxel dose reduction on survival of the randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy of weekly nab-paclitaxel (nP) with solvent-based paclitaxel (P) followed by anthracycline/cyclophosphamide for patients with early breast cancer (BC) (2018) Untch M, Jackisch C, Schneeweiss A, Schmatloch S, Aktas B, Denkert C, Schem C, et al. Conference contribution Germline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study (2018) Pohl E, Schneeweiss A, Hauke J, Moebus V, Furlanetto J, Denkert C, Fasching P, et al. Conference contribution Circulating and tumor myeloid-derived suppressor cells in resectable non-small cell lung cancer (2018) Yamauchi Y, Safi S, Blattner C, Rathinasamy A, Umansky L, Juenger S, Warth A, et al. Journal article